Хайлтын үр дүнгүүд - Colleen Burns

  • 7-н 1 - 7 үр дүнгүүдийг харуулж байна
Үр дүнг сайжруулах
  1. 1
    Sustained Weight Loss Following 12-Month Pramlintide Treatment as an Adjunct to Lifestyle Intervention in Obesity

    Sustained Weight Loss Following 12-Month Pramlintide Treatment as an Adjunct to Lifestyle Intervention in Obesity -н Steven R. Smith, Louis J. Aronne, Colleen Burns, Nicole C. Kesty, Amy E. Halseth, Christian Weyer

    Хэвлэсэн 2008
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials

    Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials -н Ralph A. DeFronzo, John B. Buse, Terri Kim, Colleen Burns, Sharon Skare, Alain Baron, Mark Fineman

    Хэвлэсэн 2016
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes

    Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabete... -н Priscilla Hollander, Alok Gupta, Raymond A Plodkowski, Frank L. Greenway, Harold Bays, Colleen Burns, Preston Klassen, Ken Fujioka

    Хэвлэсэн 2013
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies

    The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies -н John B. Buse, Ralph A. DeFronzo, Julio Rosenstock, Terri Kim, Colleen Burns, Sharon Skare, Alain Baron, Mark Fineman

    Хэвлэсэн 2015
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II)

    A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II) -н Caroline M. Apovian, Louis J. Aronne, Domenica Rubino, Christopher D. Still, Holly R. Wyatt, Colleen Burns, Dennis Kim, Eduardo Dunayevich

    Хэвлэсэн 2013
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  6. 6
    Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes

    Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes -н Ian Chapman, Barbara A. Parker, S. Doran, Christine Feinle‐Bisset, Jocelyn Wishart, S. Strobel, Y. Wang, Colleen Burns, Cameron W. Lush, C. Weyer, Michael Horowitz

    Хэвлэсэн 2005
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  7. 7
    Progressive Reduction in Body Weight after Treatment with the Amylin Analog Pramlintide in Obese Subjects: A Phase 2, Randomized, Placebo-Controlled, Dose-Escalation Study

    Progressive Reduction in Body Weight after Treatment with the Amylin Analog Pramlintide in Obese Subjects: A Phase 2, Randomized, Placebo-Controlled, Dose-Escalation Study -н Louis J. Aronne, Ken Fujioka, Vanita R. Aroda, Kim Chen, Amy E. Halseth, Nicole C. Kesty, Colleen Burns, Cameron W. Lush, Christian Weyer

    Хэвлэсэн 2007
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: